Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet.

Cell, 2019/08/22;178(5):1115-1131.e15.

Cheng CW[1], Biton M[2], Haber AL[3], Gunduz N[4], Eng G[5], Gaynor LT[6], Tripathi S[1], Calibasi-Kocal G[7], Rickelt S[1], Butty VL[8], Moreno-Serrano M[1], Iqbal AM[1], Bauer-Rowe KE[1], Imada S[9], Ulutas MS[10], Mylonas C[11], Whary MT[12], Levine SS[8], Basbinar Y[13], Hynes RO[14], Mino-Kenudson M[15], Deshpande V[15], Boyer LA[11], Fox JG[12], Terranova C[16], Rai K[16], Piwnica-Worms H[17], Mihaylova MM[18], Regev A[19], Yilmaz ÖH[20]

Affiliations

PMID: 31442404DOI: 10.1016/j.cell.2019.07.048

Impact factor: 66.85

Abstract
Little is known about how metabolites couple tissue-specific stem cell function with physiology. Here we show that, in the mammalian small intestine, the expression of Hmgcs2 (3-hydroxy-3-methylglutaryl-CoA synthetase 2), the gene encoding the rate-limiting enzyme in the production of ketone bodies, including beta-hydroxybutyrate (βOHB), distinguishes self-renewing Lgr5+ stem cells (ISCs) from differentiated cell types. Hmgcs2 loss depletes βOHB levels in Lgr5+ ISCs and skews their differentiation toward secretory cell fates, which can be rescued by exogenous βOHB and class I histone deacetylase (HDAC) inhibitor treatment. Mechanistically, βOHB acts by inhibiting HDACs to reinforce Notch signaling, instructing ISC self-renewal and lineage decisions. Notably, although a high-fat ketogenic diet elevates ISC function and post-injury regeneration through βOHB-mediated Notch signaling, a glucose-supplemented diet has the opposite effects. These findings reveal how control of βOHB-activated signaling in ISCs by diet helps to fine-tune stem cell adaptation in homeostasis and injury.

Keywords: HDAC; Hmgcs2; Intestinal stem cell; Notch; beta-hydroxybutyrate; ketogenic diet; ketone bodies

MeSH terms
More resources
EndNote: Download